SHPGY

Pharma

Shire’s application withdrawal disappoints Fabry disease foundation

A Fabry disease charity organization has voiced its disappointment over Shire’s (NASDAQ:SHPGY) withdrawal of its biologics license application to treat the disease after talks broke down between the drug company and the U.S. Food and Drug Administration. Recent interactions with the FDA led Shire to believe that it would be required to conduct additional controlled […]

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.